Generic Formulation Development

Generic Formulation Development is a pharmaceutical research process that involves the systematic design and optimization of dosage forms containing bioequivalent active ingredients to a reference innovator drug, distinguished by its focus on establishing therapeutic equivalence through formulation composition, stability, and performance characteristics while adhering to regulatory standards for market approval.

41

Publications

3.6K

Citations

158

Authors

69

Institutions

Publications per year

2017–2026

13

Authors

158

  1. MR
    M. Rost

    Universität Hamburg, Germany

    2 publications · 24 citations

    2

    h-index

  2. RG
    Rafiqul Gani

    Technical University of Denmark, Denmark

    2 publications · 89 citations

    2

    h-index

  3. KP
    Katakam Prakash

    2 publications · 57 citations

    2

    h-index

  4. VS
    Varanasim Satyanarayana

    2 publications · 57 citations

    2

    h-index

  5. SC
    Siddharth Chachad

    Dr. Reddy's Laboratories (India), India

    2 publications · 86 citations

    2

    h-index

1–5 of 158

Venues

  1. Transplantation Proceedings

    3 publications · 47 citations

    3

    h-index

  2. Computers & Chemical Engineering

    2 publications · 89 citations

    2

    h-index

  3. Asian Journal of Pharmaceutics

    AJP · 2 publications · 57 citations

    2

    h-index

  4. BioMed Research International

    1 publications · 14 citations

    1

    h-index

  5. AAPS PharmSciTech

    1 publications · 28 citations

    1

    h-index

1–5